I think CEPA is the most critical legislative tool we have to achieve that target. I think the opportunity that we have today with modernizing CEPA can bring us forward to achieve not only those global targets but also our domestic targets. One of the issues we've had in our chemicals management plan has been the fact that we have not measured performance. This has been shown by the Auditor General's reports over the years. We have not seen whether our chemical management has led to meaningful reductions in exposures and in risk to the environment. When it comes to some of the major issues and gaps that we have within CEPA when it comes to chemicals management, it's the fact that we do not require the risk assessment regimes and our risk management and regulatory regimes to consider vulnerable populations and marginalized communities that are most disproportionately affected by toxic substances. Some of the vulnerable populations could include biologically or physiologically vulnerable communities, whether it's pregnant women and children or socio-economically marginalized communities.
If we don't address those communities and provide them with the protections adequately, then we're not going to be able to meet those targets domestically and globally at this time.